Self-Monitoring Blood Glucose Market Size (2024 - 2029)

The Self-Monitoring Blood Glucose Market is projected to experience significant growth over the forecast period, driven by advancements in technology and the increasing need for effective diabetes management. The market's expansion is influenced by the rising prevalence of diabetes, which necessitates frequent monitoring of blood glucose levels, particularly for patients with insulin dependency. Technological innovations, such as cellular-connected devices that facilitate real-time data sharing and monitoring, are enhancing the ability to manage glucose levels effectively. These developments are expected to improve patient outcomes and contribute to the market's growth trajectory.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Monitoring Devices Research Single time Monitoring Devices Research Self-Monitoring Blood Glucose Industry Market Size

Market Size of Self-Monitoring Blood Glucose Industry

Self-monitoring Blood Glucose Market Summary
Study Period 2018 - 2029
Market Size (2024) USD 14.56 Billion
Market Size (2029) USD 19.70 Billion
CAGR (2024 - 2029) 6.23 %
Fastest Growing Market North America
Largest Market North America

Major Players

Self-Monitoring Blood Glucose Market Major Players

*Disclaimer: Major Players sorted in no particular order

Self-Monitoring Blood Glucose Market Analysis

The Self-Monitoring Blood Glucose Market size is estimated at USD 14.56 billion in 2024, and is expected to reach USD 19.70 billion by 2029, growing at a CAGR of 6.23% during the forecast period (2024-2029).

During the COVID-19 pandemic, hyperglycemia, caused by both stress and diabetes mellitus, could be present in patients in the intensive care unit or non-ICU patients. The maintenance of euglycemia was essential to decrease both morbidity and mortality. According to experts, inpatient use of diabetes technology in patients with proper institutional protocols was safe and improved inpatient glycemic outcomes and played a vital role in managing hypoglycemia and hyperglycemia in hospitalized patients. According to the article published by the American Association of Clinical Endocrinology in December 2022, the inpatient standard of care for glucose monitoring consisted of capillary glucose measurement using glucometers. COVID-19 treatment involved high doses of corticosteroids with subsequent hyperglycemia and the need for higher insulin doses to control glucose. This dosing required more frequent glucose monitoring with glucometer checks.

According to the International Diabetes Federation (IDF), the adult diabetes population in 2021 is approximately 537 million, and this number is going to increase by 643 million in 2030. The main diagnosis for diabetes patients is imbalances in blood glucose levels, which do not comply with the standard blood glucose levels. General lab diagnostic tests can only help physicians diagnose the disease. Patients with more fluctuations in glucose levels need to get it checked daily. Patients administering insulin need to check their blood glucose levels frequently, adjust their insulin doses, or change the medication if necessary.

Technological advancements in blood glucose meters, including cellular-connected devices that automatically upload SMBG data to secure cloud-based databases, allow for improved sharing and monitoring of SMBG data. Real-time monitoring of SMBG data presents opportunities to provide timely support to patients responding to abnormal SMBG recordings. Such diabetes remote monitoring programs can provide patients with poorly controlled diabetes additional support needed to improve critical outcomes, thereby enhancing the market prospects in the years to come.

Self-Monitoring Blood Glucose Industry Segmentation

Self-monitoring blood glucose (SMBG) is an important aid in diabetes mellitus care. Patients with diabetes can measure their blood glucose to detect hypoglycemia, adjust the insulin doses as needed, and establish the response to nutrition and pharmacotherapy. 

The Self-monitoring Blood Glucose Market is segmented into Components (Glucometer Devices, Test Strips, and Lancets) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America). The report offers the value (in USD) and volume (in Units) for the above segments.

By Component
Glucometer Devices
Test Strips
Lancets
By End User
Hospital/Clinics
Personal/Home
By Geography
North America
United States
Canada
Rest of North America
Europe
France
Germany
Italy
Spain
United Kingdom
Russia
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Asia-Pacific
Japan
South Korea
China
India
Australia
Vietnam
Malaysia
Indonesia
Philippines
Thailand
Rest of Asia-Pacific
Middle East & Africa
Saudi Arabia
Iran
Egypt
Oman
South Africa
Rest of Middle East & Africa
Need A Different Region Or Segment?
Customize Now

Self-Monitoring Blood Glucose Market Size Summary

The self-monitoring blood glucose market is poised for significant growth, driven by technological advancements and increasing adoption of glucometers in home care settings. These devices, which offer portable and convenient blood sugar monitoring, are becoming essential for patients managing diabetes, particularly those requiring frequent glucose checks. The market is benefiting from the integration of cellular-connected devices that enable real-time monitoring and data sharing, enhancing patient support and outcomes. The availability of reimbursement options for glucose meters further supports market expansion, as health insurance plans cover substantial costs, making these devices more accessible to a broader population. The market landscape is characterized by strategic collaborations and innovations, with major players like Abbott, LifeScan, and Roche leading the charge in developing advanced diabetes management solutions.

Regionally, North America holds a significant share of the market, influenced by the rising prevalence of diabetes linked to lifestyle changes and obesity. The region's focus on addressing social determinants of health and improving diabetes care through policy and organizational actions is expected to bolster market growth. The presence of numerous startups and established companies introducing innovative diabetes management platforms in the United States underscores the market's dynamic nature. As awareness of advanced diabetes devices grows, the adoption of point-of-care testing devices is expected to increase, further driving market expansion. The self-monitoring blood glucose market is anticipated to experience robust growth over the forecast period, supported by these trends and the ongoing demand for effective diabetes management solutions.

Explore More

Self-Monitoring Blood Glucose Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Component

      1. 2.1.1 Glucometer Devices

      2. 2.1.2 Test Strips

      3. 2.1.3 Lancets

    2. 2.2 By End User

      1. 2.2.1 Hospital/Clinics

      2. 2.2.2 Personal/Home

    3. 2.3 By Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Rest of North America

      2. 2.3.2 Europe

        1. 2.3.2.1 France

        2. 2.3.2.2 Germany

        3. 2.3.2.3 Italy

        4. 2.3.2.4 Spain

        5. 2.3.2.5 United Kingdom

        6. 2.3.2.6 Russia

        7. 2.3.2.7 Rest of Europe

      3. 2.3.3 Latin America

        1. 2.3.3.1 Mexico

        2. 2.3.3.2 Brazil

        3. 2.3.3.3 Rest of Latin America

      4. 2.3.4 Asia-Pacific

        1. 2.3.4.1 Japan

        2. 2.3.4.2 South Korea

        3. 2.3.4.3 China

        4. 2.3.4.4 India

        5. 2.3.4.5 Australia

        6. 2.3.4.6 Vietnam

        7. 2.3.4.7 Malaysia

        8. 2.3.4.8 Indonesia

        9. 2.3.4.9 Philippines

        10. 2.3.4.10 Thailand

        11. 2.3.4.11 Rest of Asia-Pacific

      5. 2.3.5 Middle East & Africa

        1. 2.3.5.1 Saudi Arabia

        2. 2.3.5.2 Iran

        3. 2.3.5.3 Egypt

        4. 2.3.5.4 Oman

        5. 2.3.5.5 South Africa

        6. 2.3.5.6 Rest of Middle East & Africa

Self-Monitoring Blood Glucose Market Size FAQs

The Self-Monitoring Blood Glucose Market size is expected to reach USD 14.56 billion in 2024 and grow at a CAGR of 6.23% to reach USD 19.70 billion by 2029.

In 2024, the Self-Monitoring Blood Glucose Market size is expected to reach USD 14.56 billion.

Self-Monitoring Blood Glucose Market Report Snapshots

Self-Monitoring Blood Glucose Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)